Regulatory perspectives on clinical trials for trauma, transfusion, and hemostasis
- 9 May 2005
- journal article
- review article
- Published by Wiley in Transfusion
- Vol. 45 (s1) , 14S-21S
- https://doi.org/10.1111/j.0041-1132.2005.00157.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The next generation in shock resuscitationThe Lancet, 2004
- Emily Cooley Lecture 2002: transfusion safety in the hospitalTransfusion, 2003
- Blood Transfusion, Independent of Shock Severity, Is Associated with Worse Outcome in TraumaPublished by Wolters Kluwer Health ,2003
- Distribution of the Probability of Survival Is a Strategic Issue for Randomized Trials in Critically Ill PatientsAnesthesiology, 2001
- Acute Severe Isovolemic Anemia Impairs Cognitive Function and Memory in HumansAnesthesiology, 2000
- Diaspirin Cross-Linked Hemoglobin (DCLHb) in the Treatment of Severe Traumatic Hemorrhagic ShockA Randomized Controlled Efficacy TrialJAMA, 1999
- A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical CareNew England Journal of Medicine, 1999
- Human Cardiovascular and Metabolic Response to Acute, Severe Isovolemic AnemiaJAMA, 1998
- Effect of anaemia and cardiovascular disease on surgical mortality and morbidityThe Lancet, 1996
- Clinical TrialsPublished by Oxford University Press (OUP) ,1986